Home/Filings/4/0001415889-20-000737
4//SEC Filing

BORKOWSKI EDWARD 4

Accession 0001415889-20-000737

CIK 0001604191other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:10 PM ET

Size

11.6 KB

Accession

0001415889-20-000737

Insider Transaction Report

Form 4
Period: 2020-03-10
Transactions
  • Award

    Common Stock

    2020-03-10$4.74/sh+1,319$6,252403,443 total
  • Award

    Common Stock

    2020-03-10$0.60/sh+14,584$8,750393,710 total
  • Award

    Common Stock

    2020-03-10$1.04/sh+8,414$8,751402,124 total
  • Award

    Common Stock

    2020-03-10$4.74/sh+6,330$30,004409,773 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    13,680
Footnotes (8)
  • [F1]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2019.
  • [F2]Based on the stock price at September 30, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
  • [F3]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019.
  • [F4]Based on the stock price at December 31, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
  • [F5]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2016.
  • [F6]Based on the stock price at December 31, 2016, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
  • [F7]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors during 2016.
  • [F8]Based on the stock price at April 21, 2017, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.

Issuer

AzurRx BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001197542

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:10 PM ET
Size
11.6 KB